GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Tailin Bioengineering Co Ltd (SZSE:300813) » Definitions » Capital Expenditure

Zhejiang Tailin Bioengineering Co (SZSE:300813) Capital Expenditure : ¥-10.92 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Tailin Bioengineering Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Zhejiang Tailin Bioengineering Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-1.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-10.92 Mil.

Zhejiang Tailin Bioengineering Co Capital Expenditure Historical Data

The historical data trend for Zhejiang Tailin Bioengineering Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Tailin Bioengineering Co Capital Expenditure Chart

Zhejiang Tailin Bioengineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.07 -25.91 -29.14 -176.24 -18.54

Zhejiang Tailin Bioengineering Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.61 -3.05 -4.14 -2.74 -0.99

Zhejiang Tailin Bioengineering Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-10.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Tailin Bioengineering Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Tailin Bioengineering Co Ltd (SZSE:300813) » Definitions » Capital Expenditure
Comparable Companies
SZSE:300642 SHSE:688613 SZSE:301290 SZSE:301235 SHSE:688338 SHSE:688314 SZSE:301234 SZSE:300246 SZSE:301515 BJSE:835892 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
No. 2930, Nanhuan Road, Binjiang District, Hangzhou, CHN, 310052
Website
http://www.tailingood.com
Zhejiang Tailin Bioengineering Co Ltd is engaged in designing, manufacturing, and selling the Microbial test and control equipments in China.
Executives
Xia Xin Qun Directors, executives
Ye Xing Yue Secretary Dong
Shen Zhi Lin Directors, executives
Ye Da Lin Directors, executives
Ni Wei Ju Director

Zhejiang Tailin Bioengineering Co Headlines

No Headlines